Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Army
Cipla
AstraZeneca
Queensland Health
Baxter
Chubb
Chinese Patent Office
Daiichi Sankyo

Generated: May 26, 2018

DrugPatentWatch Database Preview

UROVIST CYSTO Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Urovist Cysto patents expire, and what generic alternatives are available?

Urovist Cysto is a drug marketed by Bayer Hlthcare and is included in two NDAs.

The generic ingredient in UROVIST CYSTO is diatrizoate meglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for UROVIST CYSTO
US Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
DailyMed Link:UROVIST CYSTO at DailyMed
Drug patent expirations by year for UROVIST CYSTO
Medical Subject Heading (MeSH) Categories for UROVIST CYSTO

US Patents and Regulatory Information for UROVIST CYSTO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare UROVIST CYSTO diatrizoate meglumine SOLUTION;URETERAL 087729-001 Sep 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Hlthcare UROVIST CYSTO PEDIATRIC diatrizoate meglumine SOLUTION;URETERAL 087731-001 Sep 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Fish and Richardson
QuintilesIMS
Chinese Patent Office
Julphar
US Army
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.